BJ's stock declines as revenue rises, but misses Wall Street estimates
By Steve Gelsi
Company's stock gives back some of its gains for the year
BJ's Wholesale Club Holdings Inc.'s stock dropped about 8% Thursday after the company reported second-quarter revenue that fell short of analyst predictions, though profit beat expectations.
BJ's (BJ) said its second-quarter net income rose 10.4% to $144.99 million, or $1.08 a share, from $131.33 million, or 97 cents a share, in the year-ago quarter.
Adjusted profit totaled $1.09 a share, well ahead of the FactSet consensus estimate of $1.01 a share.
Revenue increased 4.8%, to $5.09 billion, but fell short of Wall Street analysts' expectations of $5.15 billion.
BJ's summed up the results as "strong" due to "robust membership, accelerating traffic and unit growth, and a fast-tracking digital business."
Looking ahead, BJ's said it continues to expect 2024 adjusted EPS to range from $3.75 a share to $4 a share, compared with the analyst estimate of $3.95 a share.
DA. Davidson analyst Michael Baker reiterated a buy rating and said the retailer delivered better-than-expected profit. But its sales and net income outlook implies the retailer will face lower profit margins in coming quarters, he said.
BJ's appears to be making an "investment in price" as it diverts its profits into its "customer value proposition" in order to keep the costs of its goods relatively low for consumers, he said
Ahead of Thursday's moves, BJ's stock had risen 31.4% in 2024, compared to a 17.8% gain by the S&P 500 SPX this year.
-Steve Gelsi
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-22-24 0956ET
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks